Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for COVID-19 Pneumonia and Deficiency
NCT04621058Phase 3Completed
- Sponsor
- Bioaraba Health Research Institute
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcifediol in COVID-19 pneumonia, sponsored by Bioaraba Health Research Institute. Primary endpoint: Mortality at 21 days. Started Nov 2020; status: completed.
02
Drugs
calcifediol
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04621058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621058.